166 related articles for article (PubMed ID: 9535847)
1. Mtd, a novel Bcl-2 family member activates apoptosis in the absence of heterodimerization with Bcl-2 and Bcl-XL.
Inohara N; Ekhterae D; Garcia I; Carrio R; Merino J; Merry A; Chen S; Núñez G
J Biol Chem; 1998 Apr; 273(15):8705-10. PubMed ID: 9535847
[TBL] [Abstract][Full Text] [Related]
2. Diva, a Bcl-2 homologue that binds directly to Apaf-1 and induces BH3-independent cell death.
Inohara N; Gourley TS; Carrio R; Muñiz M; Merino J; Garcia I; Koseki T; Hu Y; Chen S; Núñez G
J Biol Chem; 1998 Dec; 273(49):32479-86. PubMed ID: 9829980
[TBL] [Abstract][Full Text] [Related]
3. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
Simonian PL; Grillot DA; Merino R; Nuñez G
J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
[TBL] [Abstract][Full Text] [Related]
4. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L).
Inohara N; Ding L; Chen S; Núñez G
EMBO J; 1997 Apr; 16(7):1686-94. PubMed ID: 9130713
[TBL] [Abstract][Full Text] [Related]
5. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
Zha H; Aimé-Sempé C; Sato T; Reed JC
J Biol Chem; 1996 Mar; 271(13):7440-4. PubMed ID: 8631771
[TBL] [Abstract][Full Text] [Related]
6. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms.
Minn AJ; Kettlun CS; Liang H; Kelekar A; Vander Heiden MG; Chang BS; Fesik SW; Fill M; Thompson CB
EMBO J; 1999 Feb; 18(3):632-43. PubMed ID: 9927423
[TBL] [Abstract][Full Text] [Related]
7. Neuron-specific Bcl-2 homology 3 domain-only splice variant of Bak is anti-apoptotic in neurons, but pro-apoptotic in non-neuronal cells.
Sun YF; Yu LY; Saarma M; Timmusk T; Arumae U
J Biol Chem; 2001 May; 276(19):16240-7. PubMed ID: 11278671
[TBL] [Abstract][Full Text] [Related]
8. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
Huang DC; Adams JM; Cory S
EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
[TBL] [Abstract][Full Text] [Related]
9. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
Ottilie S; Diaz JL; Horne W; Chang J; Wang Y; Wilson G; Chang S; Weeks S; Fritz LC; Oltersdorf T
J Biol Chem; 1997 Dec; 272(49):30866-72. PubMed ID: 9388232
[TBL] [Abstract][Full Text] [Related]
10. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL.
Kelekar A; Chang BS; Harlan JE; Fesik SW; Thompson CB
Mol Cell Biol; 1997 Dec; 17(12):7040-6. PubMed ID: 9372935
[TBL] [Abstract][Full Text] [Related]
11. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.
Zha J; Harada H; Osipov K; Jockel J; Waksman G; Korsmeyer SJ
J Biol Chem; 1997 Sep; 272(39):24101-4. PubMed ID: 9305851
[TBL] [Abstract][Full Text] [Related]
12. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE
Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773
[TBL] [Abstract][Full Text] [Related]
13. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members.
Hsu SY; Lin P; Hsueh AJ
Mol Endocrinol; 1998 Sep; 12(9):1432-40. PubMed ID: 9731710
[TBL] [Abstract][Full Text] [Related]
14. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.
Yamaguchi H; Wang HG
J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of a proapoptotic Bcl-2 family member Bcl-XL/Bcl-2-associated death promoter (BAD) in rat ovary.
Kaipia A; Hsu SY; Hsueh AJ
Endocrinology; 1997 Dec; 138(12):5497-504. PubMed ID: 9389536
[TBL] [Abstract][Full Text] [Related]
16. A splicing variant of the Bcl-2 member Bok with a truncated BH3 domain induces apoptosis but does not dimerize with antiapoptotic Bcl-2 proteins in vitro.
Hsu SY; Hsueh AJ
J Biol Chem; 1998 Nov; 273(46):30139-46. PubMed ID: 9804769
[TBL] [Abstract][Full Text] [Related]
17. Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death.
Oh YJ; Uhland-Smith A; Kim JE; O'Malley KL
Brain Res Mol Brain Res; 1997 Nov; 51(1-2):133-42. PubMed ID: 9427515
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
19. The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism.
Cizeau J; Ray R; Chen G; Gietz RD; Greenberg AH
Oncogene; 2000 Nov; 19(48):5453-63. PubMed ID: 11114722
[TBL] [Abstract][Full Text] [Related]
20. BID: a novel BH3 domain-only death agonist.
Wang K; Yin XM; Chao DT; Milliman CL; Korsmeyer SJ
Genes Dev; 1996 Nov; 10(22):2859-69. PubMed ID: 8918887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
